Allan-Herndon-Dudley Syndrome synonyms

Allan-Herndon-Dudley syndrome (AHDS) is a rare X-linked intellectual disability disorder caused by mutations in the SLC16A2 gene. It is most commonly referred to by its eponymous name, though it is also frequently classified in medical literature as MCT8 deficiency or X-linked intellectual disability-hypotonia syndrome.

What are the common synonyms for Allan-Herndon-Dudley syndrome?

The medical community uses several terms to describe Allan-Herndon-Dudley syndrome, often reflecting either the clinical presentation or the underlying genetic cause. Because this condition is characterized by a defect in thyroid hormone transport, the term "MCT8 deficiency" is now frequently used in clinical research. Other synonyms you may encounter in medical records or historical literature include:

• MCT8-specific thyroid hormone cell transporter deficiency


• AHDS (the standard abbreviation)


• X-linked intellectual disability-hypotonia syndrome


• Allan-Herndon syndrome


• Monocarboxylate transporter 8 deficiency

Why does this condition have multiple names?

The variety of names for Allan-Herndon-Dudley syndrome stems from its history of clinical observation versus genetic discovery. Initially, the syndrome was named after the clinicians who first described the patient cohort. As genetic testing advanced, the identification of the SLC16A2 gene mutation allowed researchers to rename the condition based on the specific molecular defect (MCT8 deficiency). This shift helps clinicians focus on the systemic thyroid hormone abnormalities, which are hallmark features of Allan-Herndon-Dudley syndrome.

How is the condition classified in medical databases?

Standardized medical databases provide specific identifiers to help patients and providers locate accurate data. For Allan-Herndon-Dudley syndrome, the following identifiers are critical:

1. OMIM (Online Mendelian Inheritance in Man): #300523


2. Orphanet: ORPHA79 (listed as Allan-Herndon-Dudley syndrome)


3. ICD-10/11: Often coded under broader categories for X-linked intellectual disability or specific thyroid hormone metabolism disorders.

Which name should be used in a clinical setting?

While "Allan-Herndon-Dudley syndrome" remains the most recognized term in clinical practice, many specialists prefer "MCT8 deficiency" when discussing the pathophysiology and potential therapeutic interventions. If you are searching for the latest research, using both Allan-Herndon-Dudley syndrome and "MCT8 deficiency" will yield the most comprehensive results. Currently, 8 members of the DiseaseMaps.org community are navigating life with this diagnosis and can provide peer-to-peer support.

Next steps

• Consult a clinical geneticist to confirm the SLC16A2 mutation status.


• Speak with an endocrinologist experienced in thyroid hormone transport disorders.


• Join the DiseaseMaps.org community to connect with other families affected by Allan-Herndon-Dudley syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician regarding any medical condition.

References

• National Institutes of Health (NIH) GARD: Allan-Herndon-Dudley syndrome.


• Orphanet: ORPHA79, Allan-Herndon-Dudley syndrome.


• OMIM: Entry #300523, Allan-Herndon-Dudley syndrome.


• PubMed: Clinical studies on SLC16A2/MCT8 deficiency.